Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

TG Therapeutics stock skyrocketed Monday after easily beating fourth-quarter sales expectations and issuing a bullish outlook for 2025.

Elsevier. "Researchers identify a gene to guide novel therapeutics of nonalcoholic fatty liver diseases." ScienceDaily. www.sciencedaily.com / releases / 2025 / 03 / 250306120711.htm (accessed ...